Table 2.

Characteristics of participants at/before diabetes diagnosis (N=1285).

Characteristics		Lifestyle	Metformin	Placebo
	N	360	430	495
Age at diagnosis*	Median(IQR)	53.2 (46.2–61.0)	54.9 (48.0–62.5)	52.5 (46.4–60.0)
Time in study*	Median(IQR)	4.4 (2.5- 6.1)	3.0 (2.0–6.0)	2.6 (1.1–5.0)
BMI	Median(IQR)	34.5 (29.7–39.6)	33.3 (29.1–38.6)	34.8 (30.0–40.1)
Fasting plasma glucose*	Median(IQR)	117.0 (109.0–127.0)	114.0 (104.0–125.0)	118.0 (110.0–127.0)
BDI score	Median(IQR)	3.0 (0.0–7.0)	3.0 (1.0–6.0)	3.0 (1.0–6.0)
BDI ≥ 11	No	323 (89.7%)	393 (91.4%)	441 (89.1%)
	Yes	37 (10.3%)	37 (8.6%)	54 (10.9%)
Taking Anti-depressant	No	316 (87.8%)	393 (91.4%)	445 (89.9%)
	Yes	44 (12.2%)	37 (8.6%)	50 (10.1%)

This is based on the annual visit at or within six months before diabetes diagnosis with a valid BDI score.

^*Age, Time in study and FPG are significantly different in the three treatment groups (p<0.05).